Opportunity Information: Apply for HRSA 09 182
Apply for HRSA 09 182
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White Title II Formula Grants Program" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917 HIV Care Formula Grants.
- This funding opportunity was created on Nov 7, 2008 and posted on Nov 4, 2008.
- Applicants must submit their applications by Jan 5, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,209,487,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 59 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Awards under this grant program are limited to U.S. certified and uncertified poison control centers (PCCs) including those serving the U.S. territories. PCCs must be certified by a professional organization or a State government with, at a minimum, equivalent standards as the American Association of Poison Control Centers (AAPCC). The currently funded State and Territories are eligible to apply for this continuation funding.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Ryan White Title II Formula Grants Program (also known as Ryan White Part B) is a federal funding opportunity administered by the Health Resources and Services Administration (HRSA) to support HIV care and treatment services across the United States and certain U.S. jurisdictions. The program provides formula-based grant funding to all 50 states, Washington, D.C., Guam, Puerto Rico, the U.S. Virgin Islands, and the five U.S.-affiliated Pacific jurisdictions. Its central purpose is to help states and territories develop, maintain, and strengthen a comprehensive continuum of HIV care so that low-income people living with HIV, including families, can access essential medical care, life-saving medications, and the support services needed to stay engaged in treatment.
A major focus of Part B is ensuring access to core HIV clinical services and the related supports that make continuous care possible. Funds can be used for primary medical care and a range of HIV-related health services, including mental health treatment, substance use treatment, oral health services, and case management. The program also supports home health care, nutritional services, and rehabilitation services, recognizing that many people living with HIV face complex medical and social needs that can interfere with consistent treatment if not addressed. By funding both medical and supportive services, Part B is designed to reduce gaps in care and improve health outcomes by keeping people connected to providers and treatment plans.
Another central component is medication access, particularly through the AIDS Drug Assistance Program (ADAP). Part B dollars are used to help states and territories provide antiretroviral therapy and other HIV-related medications, including prophylaxis and treatment for opportunistic infections. This includes support for combination antiretroviral regimens that are standard of care for HIV treatment. The opportunity description indicates that Part B funding is delivered through multiple streams, including the Part B base formula grant, ADAP funding (including supplemental ADAP awards), and Emerging Communities grants, which are meant to respond to areas with growing HIV burdens that may not have historically received the same level of targeted resources.
In addition to these components, the opportunity notes that Minority AIDS Initiative (MAI) funds are available under a separate competition. MAI resources are intended to support HIV outreach and education in communities of color that have been disproportionately impacted by the epidemic. While MAI is related in mission to Part B, it is described as a distinct competitive process, emphasizing targeted interventions and community-focused strategies to address inequities in HIV prevention, engagement, and care.
From the posted grant record, this opportunity was listed under Funding Opportunity Number HRSA-09-182, categorized as a discretionary grant within the health funding activity area. The estimated total funding amount shown is $1,209,487,000, with an expected 59 awards, and it is associated with CFDA number 93.917 (HIV Care Formula Grants). No cost sharing or matching requirement is indicated. The posting date was November 4, 2008, with an original and current closing date of January 5, 2009, and an archive date of March 6, 2009. Contact support for access issues is routed through the HRSA Call Center (CallCenter@HRSA.GOV) and phone lines provided in the notice, and an additional information link is included to the HRSA grants page for the full announcement.
One important caveat from the source data is that the eligibility text field appears to contain information about poison control centers, which does not align with the Ryan White Part B program description that targets states and territories. In practice, Ryan White Part B formula grants are generally awarded to state and territorial agencies (or their designated entities) based on statutory formula allocations tied to HIV/AIDS case counts and other factors. Anyone using this record for application planning should verify eligibility and requirements directly in the full HRSA announcement linked in the notice to confirm the correct applicant types, submission instructions, and continuation or formula allocation conditions.
FAQs: Ryan White Title II Formula Grants Program (Ryan White Part B)
What is the Ryan White Title II Formula Grants Program (Ryan White Part B)?
The Ryan White Title II Formula Grants Program, also called Ryan White Part B, is a federal funding opportunity administered by the Health Resources and Services Administration (HRSA). It provides formula-based funding to support HIV care and treatment services, with the goal of helping states and certain U.S. jurisdictions build and sustain a comprehensive continuum of HIV care for low-income people living with HIV and their families.
What is the primary purpose of Part B funding?
The central purpose is to help states and territories develop, maintain, and strengthen a comprehensive continuum of HIV care so that low-income people living with HIV can access essential medical care, life-saving medications, and supportive services needed to stay engaged in treatment.
Who receives Part B formula grant funding?
Based on the opportunity description, formula-based grant funding is provided to all 50 states, Washington, D.C., Guam, Puerto Rico, the U.S. Virgin Islands, and the five U.S.-affiliated Pacific jurisdictions.
What kinds of services can Part B funds support?
Part B funds can be used to support primary medical care and a range of HIV-related health services and supports. The description specifically mentions mental health treatment, substance use treatment, oral health services, case management, home health care, nutritional services, and rehabilitation services, among other supports designed to reduce gaps in care and help people remain engaged in treatment.
Does Part B funding support both medical and supportive services?
Yes. The program is described as funding both core HIV clinical services and related supportive services, recognizing that complex medical and social needs can interfere with consistent treatment if not addressed.
How does Part B address medication access?
A central component is medication access through the AIDS Drug Assistance Program (ADAP). Part B dollars are used to help states and territories provide antiretroviral therapy and other HIV-related medications, including prophylaxis and treatment for opportunistic infections.
What is ADAP in the context of Part B?
ADAP stands for the AIDS Drug Assistance Program. In this opportunity description, ADAP is highlighted as a key mechanism supported by Part B funding to expand access to HIV medications, including combination antiretroviral regimens that are standard of care.
Are there multiple funding streams within Part B?
Yes. The description indicates multiple streams, including the Part B base formula grant, ADAP funding (including supplemental ADAP awards), and Emerging Communities grants.
What are Emerging Communities grants?
Emerging Communities grants are described as a funding stream intended to respond to areas with growing HIV burdens that may not have historically received the same level of targeted resources.
Is the Minority AIDS Initiative (MAI) included in Part B funding?
The opportunity notes that Minority AIDS Initiative (MAI) funds are available under a separate competition. MAI is related in mission, but it is described as a distinct competitive process rather than part of the Part B formula award itself.
What is MAI intended to support?
MAI resources are intended to support HIV outreach and education in communities of color that have been disproportionately impacted by the epidemic, with an emphasis on targeted interventions and community-focused strategies to address inequities in HIV prevention, engagement, and care.
What is the Funding Opportunity Number (FON) for this posting?
The posted grant record lists this opportunity under Funding Opportunity Number HRSA-09-182.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.917, listed as "HIV Care Formula Grants."
How is this grant categorized in the posting?
The record categorizes it as a discretionary grant within the health funding activity area.
What is the estimated total funding amount and expected number of awards?
The posted record shows an estimated total funding amount of $1,209,487,000 with an expected 59 awards.
Is cost sharing or matching required?
No cost sharing or matching requirement is indicated in the posted record.
What were the key dates listed for this opportunity?
The posting date was November 4, 2008. The original and current closing date listed was January 5, 2009. The archive date was March 6, 2009.
Who administers this opportunity?
This opportunity is administered by the Health Resources and Services Administration (HRSA).
Where can applicants get help if they have access issues or need support?
Contact support for access issues is routed through the HRSA Call Center at CallCenter@HRSA.GOV. The notice also indicates phone lines are provided in the announcement.
Where can someone find the full announcement and official details?
The record mentions an additional information link to the HRSA grants page for the full announcement. For official requirements, eligibility confirmation, and instructions, the full HRSA announcement linked in the notice is the source to rely on.
Is there anything unusual or inconsistent in the posted record that applicants should watch for?
Yes. The eligibility text field in the source data appears to contain information about poison control centers, which does not align with the Ryan White Part B program description focused on states and territories. Because of that mismatch, anyone using this record for planning should verify eligibility and requirements directly in the full HRSA announcement linked in the notice.
Based on the description, who is typically eligible for Ryan White Part B formula grants?
The description notes that, in practice, Ryan White Part B formula grants are generally awarded to state and territorial agencies (or their designated entities) based on statutory formula allocations tied to HIV/AIDS case counts and other factors. Applicants should still confirm the correct applicant types in the full HRSA announcement due to the mismatch in the eligibility text field.
What overall outcomes is Part B designed to support?
The program is designed to reduce gaps in care and improve health outcomes by keeping people connected to providers and treatment plans, supporting continuous engagement in HIV care and access to medications and essential support services.
Browse more opportunities from the same category: Health
Next opportunity: BJA FY09 National Motor Vehicle Title Information System (NMVTIS) Participation Program
Previous opportunity: Public Opinion Research/Darfur
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 09 182
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 09 182) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Maternal and Child Health Data Resource Center Apply for HRSA 09 177 Funding Number: HRSA 09 177 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Family Professional Partnerships/CSHCN Family Opportunity Act Apply for HRSA 09 149 Funding Number: HRSA 09 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Certificate in MCH Public Health Apply for HRSA 09 170 Funding Number: HRSA 09 170 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Family/Professional Partnership/ CSHCN Apply for HRSA 09 147 Funding Number: HRSA 09 147 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Scholarships for Disadvantaged Students Apply for HRSA 09 127 Funding Number: HRSA 09 127 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Exploratory Studies in the Neurobiology of Pain in Sickle Cell Disease (R01) Apply for RFA HL 09 008 Funding Number: RFA HL 09 008 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| SSA Work Incentives Planning and Assistance Projects Apply for SSA OAG 09 1 Funding Number: SSA OAG 09 1 Agency: ODISP OESP Category: Health Funding Amount: $150,000 |
| National Institutes of Health Rapid Access to Interventional Development (NIH RAID) Program (X01) Apply for PAR 09 027 Funding Number: PAR 09 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Informing Systems Biology through Genetic VariationThe Genes, Environment and Health Initiative (R21) Apply for RFA MH 09 120 Funding Number: RFA MH 09 120 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| CAM Approaches in the Management of HIV Disease and Its Complications (R01) Apply for RFA AT 09 001 Funding Number: RFA AT 09 001 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Service Expansion in Comprehensive Pharmacy Services (SEXPCPS) Apply for HRSA 09 156 Funding Number: HRSA 09 156 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Expansion in Mental Health/Substance Abuse (SEXPMHSA) Apply for HRSA 09 155 Funding Number: HRSA 09 155 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Exploratory Studies of Induced Pluripotent Stem (iPS) Cells from Healthy and Mental Health Patient Populations (R21/R33) Apply for RFA MH 09 130 Funding Number: RFA MH 09 130 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Service Expansion in Oral Health (SEXPOH) Apply for HRSA 09 154 Funding Number: HRSA 09 154 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Identifying Neighborhood Level Protective and Promotive Factors for Youth Violence (U01) Apply for RFA CE 09 008 Funding Number: RFA CE 09 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Service Area Competitions Apply for HRSA 09 210 Funding Number: HRSA 09 210 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part C EIS CATEGORICAL GRANT PROGRAM TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE Apply for HRSA 09 100 Funding Number: HRSA 09 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for PAR 08 116 Funding Number: PAR 08 116 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Capacity Building to Develop Standard Electronic Client Information Data Systems Parts C D Apply for HRSA 09 135 Funding Number: HRSA 09 135 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Adaptations of Evidence Based Parenting Programs to Engage Fathers in Child Maltreatment Prevention (U01) Apply for RFA CE 09 002 Funding Number: RFA CE 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 09 182", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.